Development

Chemical screening to find hidden Longevity gems?

Danny Sullivan -
0
Start-up NemaLife evolves from platform technology to services provider to identify chemicals that have both positive and negative effects on Longevity. The use of the...
Read more
Neural

Biological and artificial neurons linked using standard IP

Eleanor Garth -
0
A world wide web that is partly biological has been created around the globe by collaborating scientists. New nanoelectronic device research has enabled both artificial and...
Read more
Guild Living - Lockdown for Longevity
Independent living

Home alone: extend life while saving life

Eleanor Garth -
0
Most of us are at home right now - what will it be like when...
We will have Longevity drugs in the near future. it's won't cure aging, but they might allow us to curb age-related diseases and to increase Longevity.
Development

From machines to animals to humans

Danny Sullivan -
0
Exclusive with Prof Joao Pedro de Magalhaes: talking AI, indication expansion and animal models. “Will you...
Tissue/Organ

Some good news: announcing Longevity2020

Phil Newman -
0
In these challenging times, with everyone working from home and conferences pushed-back to later this...
Longevity investment is growing and we're seeing a mixture of funds and investment platforms. We chat with the founder of R42 Group
Investment

Talking Longevity investment and risk with R42 Group

Phil Newman -
0
Longevity investment is growing and we're seeing a mixture of funds and investment platforms. We...
ImStem received notification from the U.S. Food and Drug Administration (FDA) that it has lifted the hold on IMS001 for the treatment of multiple sclerosis
Drugs

FDA clears the way for AgeX’s pluripotent stem cell tech

Carla Heyworth -
0
FDA announces that ImStem drug IMS001 that uses AgeX's pluripotent stem cell technology will be available for...
TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

FREE NEWSLETTER SIGN-UP | LONGEVITY MARKET | ABOUT US | LOGIN | YOUR ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2019 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.